Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=afa1ce06-69ca-4860-8ceb-5b765bcb770b Date 12/7/2016 Company Name Cardiac Insight Mailing Address 3230 Carillon Point Kirkland, WA 98033 USA Company Description Cardiac Insight, Inc. is a privately held medical device company based in Seattle, WA, that develops advanced body worn sensing and computing technologies for applications in cardiology, respiratory and other complex disease states. Website … Continue reading “Cardiac Insight Receives $1,000,000 New Financing”
Category: Seattle
Unearth Obtains $1,500,000 Seed Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a4e335fd-3425-4b3a-b4ba-8488eba15d73 Date 12/7/2016 Company Name Unearth Mailing Address 1900 N. Northlake Way Seattle, WA 98103 USA Company Description Unearth is an early stage, Seattle startup focused on revolutionizing the construction industry using drones, remote sensing, IoT and computer vision. Website http://www.unearthlabs.com Transaction Type Venture Equity Transaction Amount $1,500,000 Transaction Round Seed Proceeds … Continue reading “Unearth Obtains $1,500,000 Seed Financing Round”
Startups: Get Free Tickets to Xconomy Intersect on Thursday
Thanks to our generous sponsors, Xconomy is able to provide complimentary tickets to a number of startups for Xconomy Intersect: Innovating Where Disciplines Collide, coming up this Thursday afternoon at 415 Westlake, in the heart of Seattle’s South Lake Union innovation neighborhood. To reserve your complimentary ticket, simply e-mail [email protected] with the following information: —Your … Continue reading “Startups: Get Free Tickets to Xconomy Intersect on Thursday”
At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial
[Corrected 3/1/17 to update trial data] Juno Therapeutics is still mulling next steps for its lead product, an experimental cancer immunotherapy now stuck in limbo. Five of 38 adult leukemia patients taking the product in a clinical trial called “Rocket” have died from severe brain swelling caused by the treatment. In an after-dinner review at … Continue reading “At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial”
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More
Two years ago at the American Society of Hematology conference, excitement, not blood, was running in the streets of San Francisco. The cancer immunotherapy known as CAR-T was the star of the show, thanks to dazzling early data that showed more patients than not saw their leukemias and lymphomas knocked into remission by the living, … Continue reading “ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More”
Retrace, a Xinova Spinout, Provides Data to Improve E-Waste Recycling
For all of its noble goals, the business of recycling old electronics and mobile phones is fraught with challenges and not very profitable. Retrace, a Seattle startup that spun out of Xinova earlier this fall, believes providing better data to recyclers and other players in the global market for used mobile phones will help. “It’s … Continue reading “Retrace, a Xinova Spinout, Provides Data to Improve E-Waste Recycling”
Impel NeuroPharma Receives $36,000,000 Series C Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=40f6d690-600d-4f30-8e9e-a1392c6a07de Date 12/6/2016 Company Name Impel NeuroPharma Mailing Address 915 East Pine Street Seattle, WA 98122 USA Company Description Seattle-based Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier. Website http://www.impelneuropharma.com Transaction Type Venture Equity Transaction Amount $36,000,000 Transaction Round Series C Proceeds Purposes The … Continue reading “Impel NeuroPharma Receives $36,000,000 Series C Financing Round”
With Nod To Biden, Senate To Say Yes To “Cures” Spending, Reform Bill
The U.S. Senate cleared the way for the 21st Century Cures Act, an omnibus healthcare spending and reform bill, by voting 85-13 to end debate this evening. It passed the House with 392 votes last week. After a final Senate vote as early as tomorrow, it will head to President Obama’s desk. The president used … Continue reading “With Nod To Biden, Senate To Say Yes To “Cures” Spending, Reform Bill”
Here’s Why You Should Attend Xconomy Intersect on Thursday
Xconomy Intersect is just three days away and if you haven’t checked out the fantastic lineup of speakers gathering in South Lake Union Thursday, now’s the time. We’re going to cover a lot of ground in this concise, afternoon program in the heart of South Lake Union. We’ll begin with a dive in to the … Continue reading “Here’s Why You Should Attend Xconomy Intersect on Thursday”
With Cowboys’ Backing, Blue Star Set to Boost Sports Startups
Dallas—Partners with a deep well of subject matter expertise and capital are on the top of any entrepreneur’s wish list. Now an accelerator tailored to sports technology startups might be giving those founders a connection to the ultimate in sports and marketing royalty: the Dallas Cowboys. The new Blue Star Accelerator, aimed at nurturing young … Continue reading “With Cowboys’ Backing, Blue Star Set to Boost Sports Startups”
The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update
[Updated, 12/5/16, 4 p.m. See below.] If you’re following cancer immunotherapy, you might feel a bit swamped by this week’s wave of clinical data from experimental programs that turn living T cells into revved-up cancer fighters. We’re updating our ongoing cancer immunotherapy trial resource with American Society of Hematology results, plus a few others we’ve … Continue reading “The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update”
Global Innovation Exchange Plans Menu of IP Options for Students
The Global Innovation Exchange, a joint effort of the University of Washington and China’s Tsinghua University, is establishing some new models for intellectual property as it begins training what backers hope will be a new generation of innovation leaders. Graduate students in the program who invent a technology or launch a startup company will have … Continue reading “Global Innovation Exchange Plans Menu of IP Options for Students”
Finagraph Secures $5,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3f90c0d8-5293-4f43-85bf-8b2552e3b252 Date 12/3/2016 Company Name Finagraph Mailing Address 15500 SE 30th Place Bellevue, WA 98007 USA Company Description Seattle-based Finagraph collects, processes, and analyzes financial data from small businesses with unparalleled accuracy, at the speed of fintech. This streamlined workflow replaces the traditional paperwork process, adding instant intelligence to best understand a … Continue reading “Finagraph Secures $5,000,000 New Funding Round”
Citing Quality Concerns, Glowforge Again Delays Laser Cutter Shipment
Earlier this week, my daughter, 4-and-a-half, looked up at the cardboard and tissue-paper butterfly we made from a kit some time ago and told me she wanted to do another one. I smiled. Christmas is coming, so I hinted to her—vaguely—about a cool new tool that would let us make all kinds of neat projects … Continue reading “Citing Quality Concerns, Glowforge Again Delays Laser Cutter Shipment”
Boston Scientific to Buy Neovasc Heart Valve Assets in $75M Deal
With sales of its minimally invasive heart valve growing in Europe and an expected launch of the product coming in the United States, Boston Scientific is now shoring up the resources behind its Lotus Valve System with a deal to acquire a piece of a key supplier that makes parts for the device. Marlborough, MA-based … Continue reading “Boston Scientific to Buy Neovasc Heart Valve Assets in $75M Deal”
This Week in Drug Pricing and Post-Election Healthcare Policy News
Healthcare news has been coming fast and furious in the fallout of the election, particularly this week. Read on below for the latest on the 21st Century Cures Act, the Trump Administration’s latest nominees, and a biopharma CEO’s warning to his peers on drug pricing. IN WASHINGTON… —The House of Representatives passed a sweeping healthcare … Continue reading “This Week in Drug Pricing and Post-Election Healthcare Policy News”
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More
We’ve packed some extra stuffing into the roundup this week to account for some burnt turkey delivered by biopharma in the few days before Thanksgiving—starting with Eli Lilly’s failed gamble in Alzheimer’s disease. Lilly wasn’t alone, however. Several companies, among them Juno Therapeutics, Arrowhead Pharmaceutials, and Nivalis Therapeutics, have had some bad news for investors … Continue reading “Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More”
An Innovation Snapshot of Medellin, Colombia
As we fly over Cuba en route from Fort Lauderdale to Medellin, I am already imbibing the upcoming culture change from the happy chaos at the departure gate in Florida. The plane is surprisingly not full and my fellow passengers, primarily Hispanics, are in a sleepy good mood. We will be arriving at 1am and … Continue reading “An Innovation Snapshot of Medellin, Colombia”
A Strategy to Spin More Startups and Inventions Out of PNNL
Rosemarie Truman has a plan to help form more companies that could commercialize the promising inventions languishing inside of Pacific Northwest National Laboratory. The model she’s implementing in her role as the federal lab’s new director of innovation impact turns the typical business plan challenge on its head: Instead of startup teams pitching judges or … Continue reading “A Strategy to Spin More Startups and Inventions Out of PNNL”
PlayFab Receives $3,154,194 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0411eea3-74cb-462b-af85-b5e689afad18 Date 12/1/2016 Company Name PlayFab Mailing Address 1601 2nd Ave Seattle, WA 98101 USA Company Description Based in Seattle, WA, PlayFab provides the industry’s most comprehensive back-end service for building and managing online games. The company was founded by James Gwertzman, PlayFab CEO who previously served as vice president of PopCap, … Continue reading “PlayFab Receives $3,154,194 New Funding Round”
Nohla Therapeutics Garners $43,500,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d56c1563-2cbe-4deb-8ab0-efe0adab9b75 Date 12/1/2016 Company Name Nohla Therapeutics Mailing Address 1616 Eastlake Ave E Seattle, WA 98102 USA Company Description Nohla Therapeutics’ Scientific Advisors provide diversified expertise across our external advisory network. Website http://www.nohlatherapeutics.com Transaction Type Venture Equity Transaction Amount $43,500,000 Transaction Round Series A Proceeds Purposes The proceeds from the financing will … Continue reading “Nohla Therapeutics Garners $43,500,000 Series A Financing”
Brushing Aside Critics, House Votes in Landslide for Cures Act
By a 392 to 26 vote, the U.S. House of Representatives has passed the omnibus healthcare legislation called the 21st Century Cures Act, bringing new funding for top Obama administration health priorities a big step closer to the outgoing president’s signature. While critics of the bill questioned whether that funding would actually materialize in coming … Continue reading “Brushing Aside Critics, House Votes in Landslide for Cures Act”
Techstars Teams with Amazon for Alexa Startup Accelerator in Seattle
Alexa, what’s the epicenter of innovation in speech as the new user interface? A good case can be made for Seattle, following an announcement today from Techstars and Amazon (NASDAQ: [[ticker:AMZN]]). Techstars, a top-tier startup accelerator with locations around the world and a major presence in Seattle since 2010, will begin a second program here … Continue reading “Techstars Teams with Amazon for Alexa Startup Accelerator in Seattle”
In Year of CAR-T Trouble, Can Bluebird, Penn Make Headway in Myeloma?
Several drugs have been approved to treat multiple myeloma, a cancer of the bone marrow, in recent years. But it remains a nasty, persistent disease. Most everyone relapses. Two rival groups, Bluebird Bio and researchers at the University of Pennsylvania, are presenting data in coming days to make a case that a cutting-edge therapy known … Continue reading “In Year of CAR-T Trouble, Can Bluebird, Penn Make Headway in Myeloma?”
RAM shift phase 2
[Editor’s note: Seattle-based sci-fi author Greg Bear has contemplated a day when intelligent machines, which are already assisting or replacing humans in manufacturing and transportation, could do his job, too. Indeed, a World Economic Forum study (PDF) predicts that technologies such as artificial intelligence and robotics will replace some 5 million jobs by 2020, while … Continue reading “RAM shift phase 2”
Textio’s Data Sharing Points to Machine Learning Business Model
In the cutthroat game of recruiting, companies are constantly eyeing the competition. Textio, a Seattle startup using machine learning to help improve the performance and reduce the bias of job listings, is taking the lid off a massive data trove it has amassed over the last two years to help its customers see how they … Continue reading “Textio’s Data Sharing Points to Machine Learning Business Model”
Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies
Two big pieces of the Trump healthcare puzzle have fallen into place. The President-elect’s transition team has nominated Georgia Republican congressman Tom Price to be Health and Human Services secretary. It has also tabbed Indiana health consultant Seema Verma to run the Centers for Medicare and Medicaid Services. In a statement, Rep. Fred Upton (R-MI), … Continue reading “Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies”
The Tough Questions You Must Discuss Before You Take the Money
If all goes well, the day will come when just one small thing will stand between you and funding for your startup: your signature on a term sheet. Most founders quickly sign on the line and get back to the business of growing their business. Smart ones set aside the paperwork, grab their business partners, … Continue reading “The Tough Questions You Must Discuss Before You Take the Money”
The Journey to a Machine That Transcribes Speech as Well as Humans
As a student at the elite Tsinghua University in the early 1980s, Xuedong Huang confronted the same challenge as all other Chinese computer users. “In China, typing was fairly difficult with a Western keyboard,” says Huang, now a Microsoft (NASDAQ: [[ticker:MSFT]]) distinguished engineer and its chief speech scientist. To answer that challenge, he helped develop … Continue reading “The Journey to a Machine That Transcribes Speech as Well as Humans”
Should We Rewrite the Human Genome?
Scientists are engineering a new living thing: a radically modified version of the lowly bacterium E. coli. In an article in Science from August, researchers at Harvard University described an ongoing project to build the genetic code of E. coli from scratch, but with major revisions to create a new strain unlike any in existence. The modified E. coli is … Continue reading “Should We Rewrite the Human Genome?”
Ad Lightning Secures $2,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d35b4823-7668-4aa8-959b-ef13c456b2eb Date 11/24/2016 Company Name Ad Lightning Mailing Address 240 2nd Ave S Seattle, WA 98104 USA Company Description Ad Lightning’s complete set of Ad Quality tools save time, improve page performance and eliminate costly user experience problems for Publishers and Ad Platforms. Website http://www.adlightning.com Transaction Type Venture Equity Transaction Amount $2,000,000 … Continue reading “Ad Lightning Secures $2,000,000 New Funding Round”
Sightbox Secures $1,800,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0fadbcc5-37d2-4a79-8155-897599c0c4ba Date 11/24/2016 Company Name Sightbox Mailing Address 921 SW Washington Street Portland, OR 97205 USA Company Description Our team handles all the details. From calling the office to shipping your contact lenses. All you need to do is show up for your exam. Website http://www.sightbox.com Transaction Type Venture Equity Transaction Amount … Continue reading “Sightbox Secures $1,800,000 New Financing Round”
Two More Deaths In Trial Halt Juno’s Top CAR-T Treatment Again
Juno Therapeutics (NASDAQ: [[ticker:JUNO]]), a developer of experimental “CAR-T” cancer therapies derived from a patient’s own immune cells, reported this morning that two more patients have died during a trial of its most advanced product, a treatment for adults with acute lymphoblastic leukemia (ALL). The Phase 2 trial, dubbed Rocket, is now on hold for … Continue reading “Two More Deaths In Trial Halt Juno’s Top CAR-T Treatment Again”
Saver Rate Ends Today for Xconomy Intersect: Innovating Where Disciplines Collide
We’re just about two weeks away from Seattle Intersect: Innovating Where Disciplines Collide—and this is your last chance to save $50. This special event takes place on Thursday, December 8th, at 415 Westlake, in the middle of Seattle’s South Lake Union innovation neighborhood. Join us for a unique view of the crossroads from which the … Continue reading “Saver Rate Ends Today for Xconomy Intersect: Innovating Where Disciplines Collide”
The Convergence of Information Technology and the Life Sciences
We are at an incredible inflection point in the traditionally distinct fields of information technology and the life sciences. These broad disciplines are converging to advance fields of study like computational biology and systems biology, resulting in new forms of therapeutics and diagnostics that could have a monumentally positive impact on human health. At DFJ … Continue reading “The Convergence of Information Technology and the Life Sciences”
Sluggish Year for IPOs, But Signs Abound of Post-Election Surge
Uncertainty surrounding this year’s presidential election has kept U.S. IPO activity at a sluggish pace—so sluggish, in fact, that this year could end with the fewest IPOs and the lowest level of capital raised since 2009, according to PitchBook data for the first nine months of 2016. But this is no time to trash talk … Continue reading “Sluggish Year for IPOs, But Signs Abound of Post-Election Surge”
Blueprint Registry Obtains $1,240,346 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=53ad42b3-01d1-4550-90e4-efbcc3bbbebf Date 11/22/2016 Company Name Blueprint Registry Mailing Address 500 Yale Ave N 1st Floor Seattle, WA 98109 USA Company Description Blueprint is revolutionizing the wedding industry industry. We are a free service with no monthly fees where you can register for your home and honeymoon in a more visual, convenient and … Continue reading “Blueprint Registry Obtains $1,240,346 New Funding”
BuildPulse Obtains $1,300,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=30af7edd-94d5-4ac8-8f80-71c98edb0af2 Date 11/21/2016 Company Name BuildPulse Mailing Address 605 1st Ave. Seattle, WA 98104 USA Company Description BuildPulse helps building owners and operators unlock the data in their buildings and HVAC systems. BuildPulse provides easy to use reports that allow anyone on the team to drill down from building to system level … Continue reading “BuildPulse Obtains $1,300,000 New Financing”
Renew Lands $3,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f9909de3-3a87-48eb-90ef-84e6b8f0aff6 Date 11/21/2016 Company Name Renew Mailing Address Undisclosed Seattle, WA 98101 USA Company Description So far the startup has hired a team of 20 in Venice Beach, California to build out the brand. It plans to roll out its initial product in the latter half of 2017. Website http://www.renew.com Transaction Type … Continue reading “Renew Lands $3,000,000 Series A Financing”
Garmentory Secures $1,299,999 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=244befdc-b2fe-4a2a-8d4a-98f05b6c3b1b Date 11/21/2016 Company Name Garmentory Mailing Address 1648 103rd Ave. SE Seattle, WA 98004 USA Company Description Garmentory is a community to shop and discover new boutiques and labels to love. 120+ boutiques, 500+ designers, one checkout. Free Shipping to US + Canada. Website http://www.garmentory.com Transaction Type Venture Equity Transaction Amount … Continue reading “Garmentory Secures $1,299,999 New Financing Round”
Seattle Week in Review: A Chill in the Air and a Flurry of Funding News
Winter is coming. Yes, I’m talking about the weather. Meanwhile, a flurry of tech news from the Seattle area emerged through the deafening cacophony of news and reaction to America’s new political reality. Read on for funding news from Tola Capital, Heptio, M87, Apptentive, Echo Health Ventures, and more. —Tola Capital, a Seattle-based venture fund, … Continue reading “Seattle Week in Review: A Chill in the Air and a Flurry of Funding News”
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More
Speculation swirled this week around the incoming U.S. president’s intent to make good on his angry campaign rhetoric on drug prices, while the Associated Press reported that naming-and-shaming—that is, Congress hauling executives into hearings and penning angry letters—certainly hasn’t done the trick. For one new kind of cholesterol drug, insurers and their agents have tried … Continue reading “Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More”
Uplevel Systems Lands $1,200,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0b65201d-01c1-402e-9a5c-126b17183ba1 Date 11/18/2016 Company Name Uplevel Systems Mailing Address 6950 SW Hampton Street Tigard, OR 97223 USA Company Description Founded in 2015, Uplevel Systems delivers managed IT services to small businesses through a channel of accomplished IT consultants nationwide. Website http://www.uplevelsystems.com Transaction Type Venture Equity Transaction Amount $1,200,000 Transaction Round Undisclosed Proceeds … Continue reading “Uplevel Systems Lands $1,200,000 New Funding Round”
Heptio Lands $8,500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94504bd0-009c-4269-b75f-7a8111cf1f80 Date 11/18/2016 Company Name Heptio Mailing Address 999 3rd Ave. Seattle, WA 98104 USA Company Description Heptio bridges the gap between enterprise IT, and the emerging world of cloud native computing. Use tools, technology and operations models pioneered by the internet giants, but built from the ground up for the modern … Continue reading “Heptio Lands $8,500,000 New Round”
Check Out the Agenda for Xconomy Intersect in Seattle Dec. 8
We’re excited to hear from a great group of leading entrepreneurs, investors, and researchers at our next event in Seattle, Xconomy Intersect, coming up on Dec. 8. We’ve just released the agenda. Here are some highlights: The high-level idea behind this event is to look for the intersections—between industries, disciplines, and cultures—yielding impactful innovations now and … Continue reading “Check Out the Agenda for Xconomy Intersect in Seattle Dec. 8”
How to Lower Drug Prices, Improve Care, and Save Pharma
I recently received a note from a longtime friend who questioned me on the issue of pharma pricing. I answered with the always-reliable alleviating-the-scourge-of-disease-through-the-miracle-of-modern-medicine defense of “free-market pricing.” My friend, who is not in the pharmaceutical business, responded: The fundamental flaw in your argument centers on the notion that there is any relevance to “market … Continue reading “How to Lower Drug Prices, Improve Care, and Save Pharma”
Apptentive Garners $3,600,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6110db7a-8ce5-40d1-8399-bf4e1e2b6dfc Date 11/17/2016 Company Name Apptentive Mailing Address 24 Roy Street Seattle, WA 98109 USA Company Description Listen to, engage with, and retain your mobile customers through Apptentive’s mobile engagement software. Start your free trial today! Website http://www.apptentive.com Transaction Type Venture Equity Transaction Amount $3,600,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes … Continue reading “Apptentive Garners $3,600,000 New Funding”
Sprinklr Acquires Little Bird for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=40ffd370-9370-435b-8180-f9a09b963124 Date 11/17/2016 Company Name Little Bird Mailing Address 506 SW 6th Ave 2nd Floor Portland, OR 97204 USA Company Description A company called Plexus Engine Inc., doing business as Little Bird, automates the process of finding and verifying social media sources. Website http://www.getlittlebird.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round … Continue reading “Sprinklr Acquires Little Bird for Undisclosed Sum”
Keeping Lead in Migraine Drug Race, Amgen Touts Data, Preps FDA Filing
The first of a new group of drugs meant to prevent migraines, not just treat their symptoms, could be headed for FDA review next year. Amgen (NASDAQ: [[ticker:AMGN]]), of Thousand Oaks, CA, said Wednesday that an experimental drug named erenumab succeeded in the second of two Phase 3 trials—a 955-patient study in people with “episodic” … Continue reading “Keeping Lead in Migraine Drug Race, Amgen Touts Data, Preps FDA Filing”
ACA or Not, Accolade Sees Growing Demand For Healthcare Innovation
As if innovating in healthcare wasn’t difficult enough, companies engaged in the endeavor now face an uncertain landscape as the incoming Trump Administration takes aim at the Affordable Care Act. Healthcare IT company Accolade, one of the bigger recent arrivals to Seattle’s healthcare innovation cluster, is watching closely. So far, CEO Rajeev Singh sees little … Continue reading “ACA or Not, Accolade Sees Growing Demand For Healthcare Innovation”